gms | German Medical Science

79. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

Deutsche Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie e. V.

30.04. - 04.05.2008, Bonn

Rhinitis medicamentosa: therapeutic effect of diode laser inferior turbinate reduction on nasal obstruction and decongestant abuse

Meeting Abstract

German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. 79th Annual Meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck Surgery. Bonn, 30.04.-04.05.2008. Düsseldorf, Köln: German Medical Science; 2008. Doc08hno80

Die elektronische Version dieses Artikels ist vollständig und ist verfügbar unter:

Veröffentlicht: 8. Juli 2008

© 2008 Caffier et al.
Dieser Artikel ist ein Open Access-Artikel und steht unter den Creative Commons Lizenzbedingungen ( Er darf vervielfältigt, verbreitet und öffentlich zugänglich gemacht werden, vorausgesetzt dass Autor und Quelle genannt werden.



Introduction: Rhinitis medicamentosa (RM) is defined as a condition of rebound nasal congestion induced by excessive or improper use of topical decongestants. The purpose of our study was to evaluate long-term outcomes of an outpatient-based diode laser inferior turbinate (IT) reduction (ITR) in therapy-refractory RM.

Methods: In a prospective clinical investigation, 40 consecutive RM patients underwent videoendoscopic ITR with a diode laser after topical anaesthetic preparation. Treatment efficiency was assessed by follow-ups 1 and 6 weeks as well as 6 and 12 months after surgery. Visual analogue scales (VAS; 0-10), rhinomanometry (RMM), IT photo documentation and the recurrent need for decongestants served for assessment of subjective and objective long-term clinical effectiveness.

Results: Preoperative addiction to decongestants lasted 5±2 years (mean±SD). There was no major bleeding requiring nasal packing, nor were there any other perioperative complications. Postoperative oedema disappeared within the first week, crusting within 6 weeks after surgery. VAS was characterized by very low values for intraoperative pain (0.4) and high postoperative patient satisfaction (7.4). After 6 months, nasal airflow data revealed a significant improvement of subjective VAS (2.9 to 7.2) and objective RMM (254 to 416 ccm/s inspiration at 150 Pa). A total of 88% of patients managed to successfully stop decongestant abuse after 6 months (73% after 1 year).

Conclusions: In therapy-refractory RM, outpatient diode laser ITR of hyperplastic IT represents a highly effective, safe, and well-tolerated treatment option that provides long-lasting improvement of nasal airflow and stopping addiction to nasal decongestants.